|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 37749 |
FusionGeneSummary for TESC_PSMA7 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: TESC_PSMA7 | Fusion gene ID: 37749 | Hgene | Tgene | Gene symbol | TESC | PSMA7 | Gene ID | 54997 | 5688 |
| Gene name | tescalcin | proteasome subunit alpha 7 | |
| Synonyms | CHP3|TSC | C6|HEL-S-276|HSPC|RC6-1|XAPC7 | |
| Cytomap | 12q24.22 | 20q13.33 | |
| Type of gene | protein-coding | protein-coding | |
| Description | calcineurin B homologous protein 3calcineurin-like EF hand protein 3 | proteasome subunit alpha type-7epididymis secretory protein Li 276proteasome (prosome, macropain) subunit, alpha type, 7proteasome subunit RC6-1proteasome subunit XAPC7proteasome subunit alpha 4testicular tissue protein Li 151 | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q96BS2 | O14818 | |
| Ensembl transtripts involved in fusion gene | ENST00000335209, ENST00000541210, ENST00000392545, ENST00000535198, | ENST00000370873, ENST00000484488, ENST00000370861, ENST00000370858, | |
| Fusion gene scores | * DoF score | 4 X 4 X 4=64 | 4 X 5 X 2=40 |
| # samples | 4 | 5 | |
| ** MAII score | log2(4/64*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/40*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: TESC [Title/Abstract] AND PSMA7 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | TESC | GO:0030854 | positive regulation of granulocyte differentiation | 20060826 |
| Hgene | TESC | GO:0032417 | positive regulation of sodium:proton antiporter activity | 18321853 |
| Hgene | TESC | GO:0050821 | protein stabilization | 18321853 |
| Hgene | TESC | GO:0051604 | protein maturation | 18321853 |
| Hgene | TESC | GO:0071300 | cellular response to retinoic acid | 20060826 |
| Hgene | TESC | GO:0072659 | protein localization to plasma membrane | 18321853 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BG474310 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000335209 | ENST00000370873 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-5UTR | ENST00000335209 | ENST00000484488 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-5UTR | ENST00000335209 | ENST00000370861 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-5UTR | ENST00000335209 | ENST00000370858 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-3CDS | ENST00000541210 | ENST00000370873 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-5UTR | ENST00000541210 | ENST00000484488 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-5UTR | ENST00000541210 | ENST00000370861 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-5UTR | ENST00000541210 | ENST00000370858 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-3CDS | ENST00000392545 | ENST00000370873 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-5UTR | ENST00000392545 | ENST00000484488 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-5UTR | ENST00000392545 | ENST00000370861 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-5UTR | ENST00000392545 | ENST00000370858 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-3CDS | ENST00000535198 | ENST00000370873 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-5UTR | ENST00000535198 | ENST00000484488 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-5UTR | ENST00000535198 | ENST00000370861 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
| intron-5UTR | ENST00000535198 | ENST00000370858 | TESC | chr12 | 117476879 | - | PSMA7 | chr20 | 60714913 | - |
Top |
FusionProtFeatures for TESC_PSMA7 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| TESC | PSMA7 |
| Functions as an integral cofactor in cell pH regulationby controlling plasma membrane-type Na(+)/H(+) exchange activity.Promotes the maturation, transport, cell surface stability andexchange activity of SLC9A1/NHE1 at the plasma membrane. Promotesthe induction of hematopoietic stem cell differentiation towardmegakaryocytic lineage. Essential for the coupling of ERK cascadeactivation with the expression of ETS family genes inmegakaryocytic differentiation. Also involved in granulocyticdifferentiation in a ERK-dependent manner. Inhibits thephosphatase activity of calcineurin. {ECO:0000269|PubMed:17717601,ECO:0000269|PubMed:18321853, ECO:0000269|PubMed:20060826}. | Component of the 20S core proteasome complex involved inthe proteolytic degradation of most intracellular proteins. Thiscomplex plays numerous essential roles within the cell byassociating with different regulatory particles. Associated withtwo 19S regulatory particles, forms the 26S proteasome and thusparticipates in the ATP-dependent degradation of ubiquitinatedproteins. The 26S proteasome plays a key role in the maintenanceof protein homeostasis by removing misfolded or damaged proteinsthat could impair cellular functions, and by removing proteinswhose functions are no longer required. Associated with the PA200or PA28, the 20S proteasome mediates ubiquitin-independent proteindegradation. This type of proteolysis is required in severalpathways including spermatogenesis (20S-PA200 complex) orgeneration of a subset of MHC class I-presented antigenic peptides(20S-PA28 complex). Inhibits the transactivation function of HIF-1A under both normoxic and hypoxia-mimicking conditions. Theinteraction with EMAP2 increases the proteasome-mediated HIF-1Adegradation under the hypoxic conditions. Plays a role inhepatitis C virus internal ribosome entry site-mediatedtranslation. Mediates nuclear translocation of the androgenreceptor (AR) and thereby enhances androgen-mediatedtransactivation. Promotes MAVS degradation and thereby negativelyregulates MAVS-mediated innate immune response.{ECO:0000269|PubMed:11389899, ECO:0000269|PubMed:11713272,ECO:0000269|PubMed:12119296, ECO:0000269|PubMed:15244466,ECO:0000269|PubMed:19442227, ECO:0000269|PubMed:19734229,ECO:0000269|PubMed:27176742, ECO:0000269|PubMed:8610016}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for TESC_PSMA7 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for TESC_PSMA7 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for TESC_PSMA7 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for TESC_PSMA7 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|